How to buy Addex Therapeutics stock - 19 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Addex Therapeutics stock

Own Addex Therapeutics stock in just a few minutes.

Addex Therapeutics Ltd is a business based in the US. Addex Therapeutics shares (ADXN) are listed on the NASDAQ and all prices are listed in US Dollars. Addex Therapeutics employs 27 staff and has a trailing 12-month revenue of around USD0.00.

How to buy shares in Addex Therapeutics

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Addex Therapeutics. Find the stock by name or ticker symbol: ADXN. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Addex Therapeutics reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Addex Therapeutics, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Addex Therapeutics. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Addex Therapeutics share price

Use our graph to track the performance of ADXN stocks over time.

Addex Therapeutics shares at a glance

Information last updated 2021-04-13.
52-week rangeUSD$7.28 - USD$17.98
50-day moving average USD$10.75
200-day moving average USD$11.65
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.56

Buy Addex Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
N/A
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Addex Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Addex Therapeutics financials

Revenue TTM USD$4.2 million
Gross profit TTM USD$-6,470,057
Return on assets TTM -28.76%
Return on equity TTM -64.08%
Profit margin 0%
Book value N/A
Market capitalisation USD$60.4 million

TTM: trailing 12 months

Shorting Addex Therapeutics shares

There are currently 983 Addex Therapeutics shares held short by investors – that's known as Addex Therapeutics's "short interest". This figure is 48.9% down from 1,925 last month.

There are a few different ways that this level of interest in shorting Addex Therapeutics shares can be evaluated.

Addex Therapeutics's "short interest ratio" (SIR)

Addex Therapeutics's "short interest ratio" (SIR) is the quantity of Addex Therapeutics shares currently shorted divided by the average quantity of Addex Therapeutics shares traded daily (recently around 16383.333333333). Addex Therapeutics's SIR currently stands at 0.06. In other words for every 100,000 Addex Therapeutics shares traded daily on the market, roughly 60 shares are currently held short.

However Addex Therapeutics's short interest can also be evaluated against the total number of Addex Therapeutics shares, or, against the total number of tradable Addex Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Addex Therapeutics's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Addex Therapeutics shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Addex Therapeutics shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Addex Therapeutics.

Find out more about how you can short Addex Therapeutics stock.

Addex Therapeutics share dividends

We're not expecting Addex Therapeutics to pay a dividend over the next 12 months.

Addex Therapeutics share price volatility

Over the last 12 months, Addex Therapeutics's shares have ranged in value from as little as $7.28 up to $17.98. A popular way to gauge a stock's volatility is its "beta".

ADXN.US volatility(beta: 1.41)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Addex Therapeutics's is 1.4059. This would suggest that Addex Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Addex Therapeutics overview

Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc. to develop mGluR2PAM compounds for the treatment of human health. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site